| Nanodrug delivery in reversing multidrug resistance in cancer cells S Kapse-Mistry, T Govender, R Srivastava, M Yergeri Frontiers in pharmacology 5, 159, 2014 | 346 | 2014 |
| An overview of tramadol and its usage in pain management and future perspective M Subedi, S Bajaj, MS Kumar, YC Mayur Biomedicine & Pharmacotherapy 111, 443-451, 2019 | 218 | 2019 |
| Tumor microenvironment targeted nanotherapy C Fernandes, D Suares, MC Yergeri Frontiers in pharmacology 9, 1230, 2018 | 154 | 2018 |
| Design of new drug molecules to be used in reversing multidrug resistance in cancer cells GJ Peters, VVS Rajendra Prasad, C Lemos, NKMYC Sathish Current cancer drug targets 9 (3), 298-306, 2009 | 111 | 2009 |
| Anti-calmodulin acridone derivatives modulate vinblastine resistance in multidrug resistant (MDR) cancer cells R Hegde, P Thimmaiah, MC Yerigeri, G Krishnegowda, KN Thimmaiah, ... European journal of medicinal chemistry 39 (2), 161-177, 2004 | 90 | 2004 |
| Targeting calmodulin in reversing multi drug resistance in cancer cells YC Mayur, S Jagadeesh, KN Thimmaiah Mini reviews in medicinal chemistry 6 (12), 1383-1389, 2006 | 62 | 2006 |
| Acridone-pyrimidine hybrids-design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies M Murahari, KV Prakash, GJ Peters, YC Mayur European journal of medicinal chemistry 139, 961-981, 2017 | 56 | 2017 |
| Transition metal complexes of a multidentate Schiff base ligand containing pyridine: synthesis, characterization, enzyme inhibitions, antioxidant properties, and molecular … MCY Ercan Bursa, Fikret Turkan, Kenan Buldurun, Nevin Turan , Abdulmelik ... Biometals 34 (2), 393-406, 2021 | 49 | 2021 |
| Targeting telomerase for its advent in cancer therapeutics S Bajaj, MS Kumar, GJ Peters, YC Mayur Medicinal Research Reviews 40 (5), 1871-1919, 2020 | 49 | 2020 |
| Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors YCM Manikanta Murahari, Vivek Mahajan, Sreenivasulu Neeladri, Maushmi S. Kumar Bioorganic Chemistry 86, 583-597, 2019 | 36 | 2019 |
| Synthesis of 2‐Fluoro N10‐Substituted Acridones and Their Cytotoxicity Studies in Sensitive and Resistant Cancer Cell Lines and Their DNA Intercalation Studies YC Mayur, Zaheeruddin, GJ Peters, C Lemos, I Kathmann, VVSR Prasad Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2009 | 35 | 2009 |
| Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2, 4-dimethylacridones as anticancer agents M Murahari, PS Kharkar, N Lonikar, YC Mayur European journal of medicinal chemistry 130, 154-170, 2017 | 31 | 2017 |
| Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies VVSR Prasad, GJ Peters, C Lemos, I Kathmann, YC Mayur European journal of pharmaceutical sciences 43 (4), 217-224, 2011 | 27 | 2011 |
| Drug-DNA Interaction Studies of Acridone-Based Derivatives. YMC Thimmaiah K, Ugarkar AG, Martis EF, Shaikh MS, Coutinho EC Nucleosides Nucleotides Nucleic Acids 34 (5), 309-31, 2015 | 26 | 2015 |
| Identification and usage of fluorescent probes as nanoparticle contrast agents in detecting cancer MS Murahari, MC Yergeri Current pharmaceutical design 19 (25), 4622-4640, 2013 | 26 | 2013 |
| Synthesis of novel 1, 3-diacetoxy-acridones as cytotoxic agents and their DNA-binding studies NK Sathish, VVS Rajendra Prasad, NM Raghavendra, SM Shanta Kumar, ... Scientia Pharmaceutica 77 (1), 19-32, 2009 | 26 | 2009 |
| Sensitization of multidrug resistant (MDR) cancer cells to vinblastine by novel acridones: correlation between anti-calmodulin activity and anti-MDR activity YC Mayur, T Padma, BH Parimala, KH Chandramouli, S Jagadeesh, ... Medicinal Chemistry 2 (1), 63-77, 2006 | 26 | 2006 |
| Cancer cell fusion: A potential target to tackle drug-resistant and metastatic cancer cells C Fernandes, P Prabhu, K Juvale, D Suares, YC Mayur Drug Discovery Today 24 (9), 1836-1844, 2019 | 24 | 2019 |
| A comprehensive review on acridone based derivatives as future anti-cancer agents and their structure activity relationships TT Yadav, M Murahari, GJ Peters, YC Mayur European journal of medicinal chemistry 239, 114527, 2022 | 22 | 2022 |
| E-drug delivery: A futuristic approach KS Yadav, S Kapse-Mistry, GJ Peters, YC Mayur Drug discovery today 24 (4), 1023-1030, 2019 | 22 | 2019 |
Maushmi S. KumarSomaiya Institute for Research and Consultancy (SIRAC), Somaiya Vidyavihar UniversityVerified email at somaiya.edu
